Fox Run Management, L.L.C. Global Blood Therapeutics, Inc. Transaction History

Fox Run Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$25.48 - $37.34 $173,595 - $254,397	-6,813 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$32.46 - $43.42 $221,149 - $295,820	6,813 New	6,813 $239,000
Q3 2020 Oct 29, 2020	SELL	$52.76 - $74.49 $231,510 - $326,862	-4,388 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$48.73 - $81.82 $54,918 - $92,211	-1,127 Reduced 20.44%	4,388 $277,000
Q2 2019 Jul 17, 2019	BUY	$52.6 - $63.29 $290,089 - $349,044	5,515 New	5,515 $290,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.